Success Metrics

Clinical Success Rate
95.0%

Based on 19 completed trials

Completion Rate
95%(19/20)
Active Trials
5(13%)
Results Posted
16%(3 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_4
9
24%
Ph phase_3
6
16%
Ph early_phase_1
4
11%
Ph phase_1
1
3%
Ph not_applicable
17
45%

Phase Distribution

5

Early Stage

0

Mid Stage

15

Late Stage

Phase Distribution37 total trials
Early Phase 1First-in-human
4(10.8%)
Phase 1Safety & dosage
1(2.7%)
Phase 3Large-scale testing
6(16.2%)
Phase 4Post-market surveillance
9(24.3%)
N/ANon-phased studies
17(45.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.5%

19 of 21 finished

Non-Completion Rate

9.5%

2 ended early

Currently Active

5

trials recruiting

Total Trials

38

all time

Status Distribution
Active(8)
Completed(19)
Terminated(2)
Other(9)

Detailed Status

Completed19
unknown9
Recruiting5
Not yet recruiting3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
5
Success Rate
95.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (10.8%)
Phase 11 (2.7%)
Phase 36 (16.2%)
Phase 49 (24.3%)
N/A17 (45.9%)

Trials by Status

withdrawn13%
completed1950%
terminated13%
not_yet_recruiting38%
recruiting513%
unknown924%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT05302986Phase 3

Effect on Post-operative Pain of Tranexamic Acid Injection During Shoulder Surgery

Completed
NCT03540368Not Applicable

Tranexamic Acid for The Treatment of Gastrointestinal Bleeding

Completed
NCT05836831Phase 4

Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage

Recruiting
NCT06450392Phase 4

The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery

Recruiting
NCT04387305Phase 3

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study

Not Yet Recruiting
NCT05441592Phase 4

A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery

Completed
NCT05840471Not Applicable

Tranexamic Acid as an Intervention in Abruptio Placenta

Completed
NCT05759156Not Applicable

Tranexamic Acid in Patients for Caesarian Delivery.

Completed
NCT05688111Not Applicable

Tranexamic Acid as an Intervention in Placenta Previa

Completed
NCT04630886Early Phase 1

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

Terminated
NCT06604325Not Applicable

Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.

Recruiting
NCT06010368Phase 3

Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section

Not Yet Recruiting
NCT06522984Not Applicable

Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid

Recruiting
NCT06516419Not Applicable

Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy

Recruiting
NCT04724772Phase 3

Use of Tranexamic Acid in Blepharoplasties

Withdrawn
NCT06509256Early Phase 1

Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery

Not Yet Recruiting
NCT06301204Not Applicable

Effectiveness Of Tranexamic Acıd Application Wıth Different Doses On Bleeding, Edema And Physician Comfort In Orthognathıc Surgery Patients

Completed
NCT05024253Phase 3

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

Completed
NCT06244498

Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty

Completed
NCT04996368Not Applicable

A Randomized Comparison of Two Doses of Tranexamic Acid in Open-Heart Surgery

Completed

Drug Details

Intervention Type
DRUG
Total Trials
38